Biocompatible gemcitabine-based nanomedicine engineered by Flow Focusing® for efficient antitumor activity

International Journal of Pharmaceutics

Volumn 443, Issue 1-2, 2013, Pages 103-109

  Martín Banderas, Lucía ^a   Sáez Fernández, Eva ^b   Holgado, M Ángeles ^a   Durán Lobato, M Matilde ^a   Prados, José C ^c   Melguizo, Consolación ^c   Arias, José L ^b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Antitumor drug; Double emulsion solvent evaporation; Flow Focusing ; Gemcitabine; Nanoparticles; Poly(d,l lactide co glycolide)

Indexed keywords

GEMCITABINE; POLYGLACTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD COMPATIBILITY; COMPARATIVE STUDY; CONTROL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SYNTHESIS; ELECTROPHORESIS; FLOW FOCUSING; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOMEDICINE; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; BIOCOMPATIBLE MATERIALS; CELL SURVIVAL; COLLOIDS; DEOXYCYTIDINE; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; HUMANS; LACTIC ACID; MCF-7 CELLS; NANOPARTICLES; PARTICLE SIZE; POLYGLYCOLIC ACID; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 84873038614     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.12.048     Document Type: Article

References (45)

1. J.L. Arias Drug targeting strategies in cancer treatment: an overview Mini Rev. Med. Chem. 11 2011 1 17
2. J.L. Arias, L.H. Reddy, and P. Couvreur Polymeric nanoparticulate system augmented the anticancer therapeutic efficacy of gemcitabine J. Drug Target. 17 2009 586 598
3. J.L. Arias, L.H. Reddy, and P. Couvreur Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system Biomacromolecules 12 2011 97 104
4. 4/chitosan nanocomposite for magnetic drug targeting to cancer J. Mater. Chem. 22 2012 7622 7632
5. K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, A.G. Karydas, and D.S. Ithakissios PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties J. Control. Release 79 2002 123 135
6. F. Bekkara-Aounallah, R. Gref, M. Othman, L.H. Reddy, B. Pili, V. Allain, C. Bourgaux, H. Hillaireau, S. Lepêtre-Mouelhi, D. Desmaële, J. Nicolas, N. Chafi, and P. Couvreur Novel PEGylated nanoassemblies made of self-assembled squalenoyl nucleoside analogues Adv. Funct. Mater. 18 2008 3715 3725
7. E.A. Bender, M.D. Adorne, L.M. Colomé, D.S. Abdalla, S.S. Guterres, and A.R. Pohlmann Hemocompatibility of poly(ε-caprolactone) lipid-core nanocapsules stabilized with polysorbate 80-lecithin and uncoated or coated with chitosan Int. J. Pharm. 426 2012 271 279
8. M.D. Blanco, R.L. Sastre, C. Teijón, R. Olmo, and J.M. Teijón 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(lactide-co-glycolide) polymers: characterization and drug release J. Microencapsul. 22 2005 671 682
9. C. Bornmann, R. Graeser, N. Esser, V. Ziroli, P. Jantscheff, T. Keck, C. Unger, U.T. Hopt, U. Adam, C. Schaechtele, U. Massing, and E. von Dobschuetz A new liposomal formulation of gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging Cancer Chemother. Pharmacol. 61 2008 395 405
10. M. Celano, M.G. Calvagno, S. Bulotta, D. Paolino, F. Arturi, D. Rotiroti, S. Filetti, M. Fresta, and D. Russo Cytotoxic effects of gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells BMC Cancer 4 2004 63
11. S.S. Chakravarthi, S. De, D.W. Miller, and D.H. Robinson Comparison of anti-tumor efficacy of paclitaxel delivered in nano- and microparticles Int. J. Pharm. 383 2010 37 44
12. J.M. Chan, L. Zhang, K.P. Yuet, G. Liao, J.W. Rhee, R. Langer, and O.C. Farokhzad PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery Biomaterials 30 2009 1627 1634
13. M.J. Cózar-Bernal, M.A. Holgado, J.L. Arias, I. Muñoz-Rubio, L. Martín-Banderas, J. Álvarez-Fuentes, and M. Fernández-Arévalo Insulin-loaded PLGA microparticles: flow focusing versus double emulsion/solvent evaporation J. Microencapsul. 28 2011 430 441
14. B.C. Dash, G. Réthoré, M. Monaghan, K. Fitzgerald, W. Gallagher, and A. Pandit The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility Biomaterials 31 2010 8818-8197
15. S. Díez, and C. Tros de Ilarduya Versatility of biodegradable poly(d,l-lactic-co-glycolic acid) microspheres for plasmid DNA delivery Eur. J. Pharm. Biopharm. 63 2006 188 197
16. K. Dillen, W. Weyenberg, J. Vandervoort, and A. Ludwig The influence of the use of viscosifying agents as dispersion media on the drug release properties from PLGA nanoparticles Eur. J. Pharm. Biopharm. 58 2004 539 549
17. A. Dueñas-Gonzalez, J. Coronel, and L. Cetina Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer Expert Opin. Drug Metab. Toxicol. 7 2011 1601 1612
18. X. Fu, Q. Ping, and Y. Gao Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres J. Microencapsul. 22 2005 57 66
19. 4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model J. Drug Target. 15 2007 445 453
20. C. Gómez-Gaete, N. Tsapis, M. Besnard, A. Bochot, and E. Fattal Encapsulation of dexamethasone into biodegradable polymeric nanoparticles Int. J. Pharm. 331 2007 153 159
21. M.A. Holgado, J.L. Arias, M.J. Cózar, J. Álvarez-Fuentes, A.M. Gañán-Calvo, and M. Fernández-Arévalo Synthesis of lidocaine-loaded PLGA microparticles by flow focusing: effects on drug loading and release properties Int. J. Pharm. 358 2008 27 35
22. M.A. Holgado, M.J. Cózar-Bernal, S. Salas, J.L. Arias, J. Alvarez-Fuentes, and M. Fernández-Arévalo Protein-loaded PLGA microparticles engineered by flow focusing: physicochemical characterization and protein detection by reversed-phase HPLC Int. J. Pharm. 380 2009 147 154
23. M.A. Holgado, J. Alvarez-Fuentes, M. Fernández-Arévalo, and J.L. Arias Possibilities of poly(d,l-lactide-co-glycolide) in the formulation of nanomedicines against cancer Curr. Drug Targets 12 2011 1096 1111
24. M.A. Ibrahim, A. Ismail, M.I. Fetouh, and A. Göpferich Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres J. Control. Release 106 2005 241 252
25. R. Krishna, and L.D. Mayer Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs Eur. J. Pharm. Sci. 11 2000 265 283
26. N. Kumar, M.N.V. Ravikumar, and A.J. Domb Biodegradable block copolymers Adv. Drug Deliv. Rev. 53 2001 23 44
27. X. Luan, and R. Bodmeier Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems J. Control. Release 110 2006 266 272
28. L. Martín-Banderas, M. Flores-Mosquera, P. Riesco-Chueca, A. Rodríguez-Gil, A. Cebolla, S. Chávez, and A.M. Gañán-Calvo Flow focusing: a versatile technology to produce size-controlled and specific-morphology microparticles Small 1 2005 688 692
29. L. Martín-Banderas, A. Rodríguez-Gil, A. Cebolla, S. Chávez, T. Berdún-Álvarez, J.M. Fernández, M. Flores-Mosquera, and A.M. Gañán-Calvo Towards a high throughput production of uniform encoded microparticles Adv. Mater. 18 2006 559 564
30. ® technology to produce tobramycin-loaded PLGA microparticles for pulmonary drug delivery Med. Chem. 8 2012 533 540
31. A. Matsuda, and T. Sasaki Antitumor activity of sugar-modified cytosine nucleosides Cancer Sci. 95 2004 105 111
32. G. Mittal, D.K. Sahana, V. Bhardwaj, and M.N.V. Ravi Kumar Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo J. Control. Release 119 2007 77 85
33. T. Musumeci, C.A. Ventura, I. Giannone, B. Ruozi, L. Montenegro, R. Pignatello, and G. Puglisi PLA/PLGA nanoparticles for sustained release of docetaxel Int. J. Pharm. 325 2006 172 179
34. S. Nobili, I. Landini, B. Giglioni, and E. Mini Pharmacological strategies for overcoming multidrug resistance Curr. Drug Targets 7 2006 861 879
35. R.W. O'Brien, and L.R. White Electrophoretic mobility of a spherical colloidal particle J. Chem. Soc., Faraday Trans. 2 1978 1607 1626
36. L.N. Okassa, H. Marchais, L. Douziech-Eyrolles, K. Hervé, S. Cohen-Jonathan, E. Munnier, M. Soucé, C. Linassier, P. Dubois, and I. Chourpa Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles Eur. J. Pharm. Biopharm. 67 2007 31 38
37. L.H. Reddy, and P. Couvreur Novel approaches to deliver gemcitabine to cancers Curr. Pharm. Des. 14 2008 1124 1137
38. D.K. Sahana, G. Mittal, V. Bhardwaj, and M.N.V. Ravikumar PLGA nanoparticles for oral delivery of hydrophobic drugs: influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug J. Pharm. Sci. 97 2008 1530 1542
39. M. Shakweh, M. Besnard, V. Nicolas, and E. Fattal Poly(lactide-co- glycolide) particles of different physicochemical properties and their uptake by Peyer's patches in mice Eur. J. Pharm. Biopharm. 61 2005 1 13
40. B. Stella, S. Arpicco, F. Rocco, V. Marsaud, J.M. Renoir, L. Cattel, and P. Couvreur Encapsulation of gemcitabine lipophilic derivatives into polycyanoacrylate nanospheres and nanocapsules Int. J. Pharm. 344 2007 71 77
41. C.O. Sullivan, and C. Birkinshaw In vitro degradation of insulin-loaded poly(n-butylcyanoacrylate) nanoparticles Biomaterials 25 2004 4375 4382
42. C. Vauthier, and K. Bouchemal Methods for the preparation and manufacture of polymeric nanoparticles Pharm. Res. 26 2009 1025 1058
43. 3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery Int. J. Pharm. 308 2006 160 167
44. H.L. Wong, R. Bendayan, A.M. Rauth, Y. Li, and X.Y. Wu Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles Adv. Drug Deliv. Rev. 59 2007 491 504
45. H.S. Yoo, K.H. Lee, J.E. Oh, and T.G. Park In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates J. Control. Release 68 2000 419 431